Eledon Pharmaceuticals, Inc. (ELDN) Misses Q1 EPS by 15c

Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN) reported Q1 EPS of ($0.75), $0.15 worse than the analyst estimate of ($0.60). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .

For earnings history and earnings-related data on Eledon Pharmaceuticals, Inc. (ELDN) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• StoneX on Mama’s Creations (MAMA): 'We Remain High-Conviction Buyers'
• StoneX Reiterates Hold Rating on Old Dominion Freight Line (ODFL) on QTD Operating Metrics